Hims & Hers’ International Revenue Explodes To $131 Million — Eucalyptus Changes The Map!

Hims & Hers Health reported second-quarter 2026 results marked by strong growth and continued investment in technology, broader offerings, and international expansion. Revenue increased nearly 40% year-over-year to more than $753 million, supported by 300,000 net new subscribers, bringing the total to nearly 3 million. U.S. revenue reached $622 million, with domestic growth accelerating to 16% on an expanded weight loss portfolio. International revenue rose more than 17-fold to $131 million, including approximately $40 million from Eucalyptus following its June acquisition. The U.K., Australia, and Germany now each exceed $100 million in annualized revenue, while Canada is approaching that level. The company is increasingly integrating artificial intelligence into its platform, shifting from traditional telehealth toward an AI-native health model focused on personalization, clinical support, and efficiency. Early AI deployment within Hers weight loss has tripled customer engagement and reduced nonclinical support queries by nearly 50%.